We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost effectiveness of intracameral cefuroxime prophylaxis and its efficacy in preventing endophthalmitis after cataract surgery in a referral hospital.
- Authors
da Silva Conci, Lívia; Pinheiro Favarato, Arthur; Grobberio Pinheiro, Alexandre
- Abstract
To present the results of a retrospective study regarding the clinical and economic impact of intracameral cefuroxime administration to prevent endophthalmitis during cataract surgery in a referral hospital. Methods: This study included 16,902 eyes from patients who had undergone cataract surgery between 2013 and 2017. From May 2014 onwards, all patients received routine intracameral injections of 1 mg cefuroxime (10 mg/1 mL) after phacoemulsification. The prophylactic efficacy was evaluated using the relative risk ratio, whereas the economic impact was evaluated using number needed to treat to avoid endophthalmitis. Results: Before introducing cefuroxime, 3,407 cataract surgeries were performed using the phacoemulsification technique, and 7 post-operatory cases of endophthalmitis occurred (0.2% incidence). After introducing the cefuroxime protocol, 13,495 surgeries were performed, and 4 endophthalmitis cases were registered (0.03% incidence). Cefuroxime was identified as a protective factor against the development of endophthalmitis [risk ratio = 14%, p=0.002, 95% confidence interval (CI) 95%, 4%-49%], with an economic impact of number needed to treat = 568. The potential savings with cefuroxime was approximately US $2,334.36 for every 568 patients treated. Conclusion: The incidence of endophthalmitis decreased by 86% (risk ratio = 14%, p=0.002, 95% CI, 4%-49%) after introducing intracameral cefuroxime prophylaxis at the study hospital. The results presented herein provide strong evidence for the use of cefuroxime in endophthalmitis prophylaxis after phacoemulsification surgeries, outperforming the alternative by providing both economic and clinical benefits.
- Subjects
CATARACT surgery; ANTIBIOTIC prophylaxis; PHACOEMULSIFICATION; CEFUROXIME; COST effectiveness; ENDOPHTHALMITIS; PREVENTIVE medicine
- Publication
Arquivos Brasileiros de Oftalmologia, 2023, Vol 86, Issue 4, p308
- ISSN
0004-2749
- Publication type
Article
- DOI
10.5935/0004-2749.20230052